Squarepoint Ops »

Nektar Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 35k 56.90

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)

View all positions for Squarepoint Ops

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics